Polymerase-1 pathway activation in acute multiple sclerosis relapse-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Polymerase-1 pathway activation in acute multiple sclerosis relapse

Published:2018-12 Issue:12 Volume:17 Page:1235-1239
ISSN:1568-9972
Container-title:Autoimmunity Reviews
language:en
Short-container-title:Autoimmunity Reviews

Author:

Achiron Anat,Zilkha-Falb Rina,Feldman Anna,Bovim Maria,Rozen Onn,Sarova-Pinhas Ida,Magalashvili David,Dolev Mark,Menascu Shay,Gurevich Michael

Funder

Sheba MSC research

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference30 articles.

1. Multiple sclerosis: a review;McAlpine;Br Med J,1973

2. Predictors of long-term disability accrual in relapse-onset multiple sclerosis;Jokubaitis;Ann Neurol,2016

3. Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients;Confavreux;Brain,1980

4. The natural history of multiple sclerosis: a geographical based study. II. Predictive value of the early clinical course;Weinshenker;Brain,1989

5. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process;Confavreux;Brain,2003

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of Novel Key Genes and Pathways in Multiple Sclerosis Based on Weighted Gene Coexpression Network Analysis and Long Noncoding RNA-Associated Competing Endogenous RNA Network;Oxidative Medicine and Cellular Longevity;2022-03-02

2. Blood platelet RNA enables the detection of multiple sclerosis;Multiple Sclerosis Journal - Experimental, Translational and Clinical;2020-07

3. Placing CD20-targeted B cell depletion in multiple sclerosis therapeutic scenario: Present and future perspectives;Autoimmunity Reviews;2019-07

4. Efficacy and safety of rituximab for relapsing-remitting multiple sclerosis: A systematic review and meta-analysis;Autoimmunity Reviews;2019-05

5. A review of the evidence for a natalizumab exit strategy for patients with multiple sclerosis;Autoimmunity Reviews;2019-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3